Sports Medicine Market (2014-2020): The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments

Sports medicines refer to a field of medicines, involved with treatment and prevention of injuries or disorders that are caused by participation in sports and exercise. European sports medicines market is growing at the significant rate due to increasing incidence of sport injuries and rising government funding in this field. In addition, various organizations such as the European College of Sports and Exercise Physicians and the European Federation of Sports Medicine (EFSM), are working closely to spread awareness about sport injuries and their treatment procedures in the European society. Implants such as artificial knee, meniscus and cartilage may be used for bone and cartilage reconstruction. Ligament and tendon surgeries are the most common type of sports injury surgeries that involve strains, cramps, sprains, tendon tear, ligament tear and muscle tears. On the basis of type of products, the European sports medicines market can be segmented into arthroscopy devices, braces, prosthetics, artificial joint implants, orthobiologics, fracture repair devices and performance monitoring devices.

Factors such as aging population, innovation of some new techniques that are less invasive in nature and rising incidence of sports injuries are driving the European sports medicines market. According to the European Injury Database (EU IDB) catalogue of sports, about 4.5 million people above 15 years of age are treated in hospitals for sports injuries every year. In addition, increased obesity rate, lack of availability of other substitutes and rising healthcare expenditures are driving the European sports medicines market. However, factors such as lack of awareness among people for sport injuries treatments, less economic growth, rising cost of surgeries and limited claim on surgeries by insurers are restraining the European sports medicines market.

Increase in the participation in sports and improvement in the healthcare facilities are expected to offer good opportunities for European sports medicines market. In addition, growing popularity of robot-assisted surgeries is expected to boost up the European sports medicines market. Some of the latest trends that have been observed in the European sports medicines market include shift of focus from metallic implants to biosorbable implants. In addition, companies are focusing on emerging countries for their geographical expansion.

Request Brochure of this Report: http://www.persistencemarketresearch.com/samples/3171

Some of the major companies dealing in the European sports medicines market are DePuy Mitek, Arthrex, Smith & Nephew, MTF Sports Medicine and Stryker. Other companies which have significant presence in the Europeans sports medicines market are Tornier, Stryker, ArthroCare, Cayenne Medical, Zimmer, MedShape, Genzyme, ConMed Linvatec, Anika Therapeutics, Biomet, Karl Storz, Wright Medical and Covidien.

Request to view TOC: http://www.persistencemarketresearch.com/toc/3171

Key points covered in the report

• Report segments the market on the basis of types, application, products, technology, etc (as applicable)
• The report covers geographic segmentation
  • North America
  • Europe
  • Asia
  • RoW
• The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
• The report provides company profiles of some of the leading companies operating in the market
• The report also provides porters five forces analysis of the market.